MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports.

MSD and Moderna start a third phase 3 trial of their V940 cancer vaccine, their second in early-stage lung cancer.

A stunning century on a dry Headingley track, that propelled India to 471 in the first innings, once again erupted the long-standing debate on "India's greatest-ever Test wicketkeeper-batter ...

EcoFlow RAPID: next-generation power banks for fast charging anywhere Large capacity, high wattage output, and monitoring from an app make these some of the best power banks out there ...

Learn more about the MS Emerging Markets Debt (MSD: XNYS) fund quote with Morningstar rating and analysis including NAV, star rating, asset allocation, capital gains, and dividends to help you ...

The formation of a stable and adherent oxide layer on the Ti-6Al-4V alloy can improve the mechanical and corrosion resistance of this material. This work studied the creep behavior of Ti-6Al-4V alloy ...

In this work, samples of the Ti-6Al-4V alloy were produced by combining different laser powers and scanning speeds in order to generate different energy density values (VED) with subsequent ...

The very best smartphones you can buy right now, with options from Apple, Samsung, Google, Motorola and more.